Nam Chul Kim

3PUBLICATIONS
0CO-AUTHORS
Neurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 24, 2024
FDA-approved PDE4 inhibitors alleviate the dominant toxicity of ALS-FTD-associated CHCHD10S59L by reducing the PINK1/Parkin pathway.

Swati Maitra, Minwoo Baek, Yun-Jeong Choe

|Jun 19, 2024
FDA-approved PDE4 inhibitors reduce the dominant toxicity of ALS-FTD-associated CHCHD10 S59L.

Swati Maitra, Minwoo Baek, Yun-Jeong Choe

|Mar 27, 2021
TDP-43 and PINK1 mediate CHCHD10S59L mutation-induced defects in Drosophila and in vitro.

Minwoo Baek, Yun-Jeong Choe, Sylvie Bannwarth

Pageof 1

Frequent Collaborators